Cargando…
Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif
Antibiotics target key biological processes that include protein synthesis. Bacteria respond by developing resistance, which increases rapidly due to antibiotics overuse. Mupirocin, a clinically used natural antibiotic, inhibits isoleucyl-tRNA synthetase (IleRS), an enzyme that links isoleucine to i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485003/ https://www.ncbi.nlm.nih.gov/pubmed/37679387 http://dx.doi.org/10.1038/s41467-023-41244-3 |
_version_ | 1785102699004428288 |
---|---|
author | Brkic, A. Leibundgut, M. Jablonska, J. Zanki, V. Car, Z. Petrovic Perokovic, V. Marsavelski, A. Ban, N. Gruic-Sovulj, I. |
author_facet | Brkic, A. Leibundgut, M. Jablonska, J. Zanki, V. Car, Z. Petrovic Perokovic, V. Marsavelski, A. Ban, N. Gruic-Sovulj, I. |
author_sort | Brkic, A. |
collection | PubMed |
description | Antibiotics target key biological processes that include protein synthesis. Bacteria respond by developing resistance, which increases rapidly due to antibiotics overuse. Mupirocin, a clinically used natural antibiotic, inhibits isoleucyl-tRNA synthetase (IleRS), an enzyme that links isoleucine to its tRNA(Ile) for protein synthesis. Two IleRSs, mupirocin-sensitive IleRS1 and resistant IleRS2, coexist in bacteria. The latter may also be found in resistant Staphylococcus aureus clinical isolates. Here, we describe the structural basis of mupirocin resistance and unravel a mechanism of hyper-resistance evolved by some IleRS2 proteins. We surprisingly find that an up to 10(3)-fold increase in resistance originates from alteration of the HIGH motif, a signature motif of the class I aminoacyl-tRNA synthetases to which IleRSs belong. The structural analysis demonstrates how an altered HIGH motif could be adopted in IleRS2 but not IleRS1, providing insight into an elegant mechanism for coevolution of the key catalytic motif and associated antibiotic resistance. |
format | Online Article Text |
id | pubmed-10485003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104850032023-09-09 Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif Brkic, A. Leibundgut, M. Jablonska, J. Zanki, V. Car, Z. Petrovic Perokovic, V. Marsavelski, A. Ban, N. Gruic-Sovulj, I. Nat Commun Article Antibiotics target key biological processes that include protein synthesis. Bacteria respond by developing resistance, which increases rapidly due to antibiotics overuse. Mupirocin, a clinically used natural antibiotic, inhibits isoleucyl-tRNA synthetase (IleRS), an enzyme that links isoleucine to its tRNA(Ile) for protein synthesis. Two IleRSs, mupirocin-sensitive IleRS1 and resistant IleRS2, coexist in bacteria. The latter may also be found in resistant Staphylococcus aureus clinical isolates. Here, we describe the structural basis of mupirocin resistance and unravel a mechanism of hyper-resistance evolved by some IleRS2 proteins. We surprisingly find that an up to 10(3)-fold increase in resistance originates from alteration of the HIGH motif, a signature motif of the class I aminoacyl-tRNA synthetases to which IleRSs belong. The structural analysis demonstrates how an altered HIGH motif could be adopted in IleRS2 but not IleRS1, providing insight into an elegant mechanism for coevolution of the key catalytic motif and associated antibiotic resistance. Nature Publishing Group UK 2023-09-07 /pmc/articles/PMC10485003/ /pubmed/37679387 http://dx.doi.org/10.1038/s41467-023-41244-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Brkic, A. Leibundgut, M. Jablonska, J. Zanki, V. Car, Z. Petrovic Perokovic, V. Marsavelski, A. Ban, N. Gruic-Sovulj, I. Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title | Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title_full | Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title_fullStr | Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title_full_unstemmed | Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title_short | Antibiotic hyper-resistance in a class I aminoacyl-tRNA synthetase with altered active site signature motif |
title_sort | antibiotic hyper-resistance in a class i aminoacyl-trna synthetase with altered active site signature motif |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485003/ https://www.ncbi.nlm.nih.gov/pubmed/37679387 http://dx.doi.org/10.1038/s41467-023-41244-3 |
work_keys_str_mv | AT brkica antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT leibundgutm antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT jablonskaj antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT zankiv antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT carz antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT petrovicperokovicv antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT marsavelskia antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT bann antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif AT gruicsovulji antibiotichyperresistanceinaclassiaminoacyltrnasynthetasewithalteredactivesitesignaturemotif |